Bruce Dezube

WORK HISTORY

EDUCATION

ABOUT BRUCE DEZUBE

Extensive clinic drug development experience at major pharmaceutical companies. Leadership of clinical team. Knowledgeable with developing clinical development plans, protocols, medical monitoring of multiple clinical trials, pharmacovigilance, clinical team management, data analysis, case report form development, authoring Investigational Brochures, ensuring quality of documents through rigorous timelines, filing Investigational New Drug (IND) applications, Clinical Study Reports; successful applications for Breakthrough Designation, Regenerative Medicine Advanced Therapy (RMAT) Designation, and Orphan Drug Designation. Comprehensive experience with small molecules, biologics, CAR T-cell therapy, and gene therapy. In addition, performed due diligence as the clinical lead on a number of biotechnology companies. Diverse experience includes fostering relationships with large number of academic physicians, working on strategy, creating educational programs for physicians, and development of clinical trial protocols. Extensive presentations both in internal and external settings including at major Academic Medical Centers and international congresses. Triple Board Certified- Internal Medicine, Hematology, Oncology; member of numerous organizations, holder of scientific patents, and author of numerous scientific journals (more than 200 on PubMed).Selected Achievements:• Developed and implemented clear regulatory strategy which resulted in key registrational trials and drug approvals• Key participant in investor interface; articulated clinical and corporate strategies to public and private investors and research analysts• Fostered procedural and process changes to clinical trials that enabled enrollment rate to increase by 100%